Related Experiment Video
Updated: Aug 10, 2026

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
Published on: June 17, 2015
Mental Disorders in People Affected by Thalidomide
Alexander Niecke1, Klaus Peters, Christina Samel
1Department of Psychosomatics and Psychotherapy, University Hospital Cologne; Department of Orthopedics and Osteology, Dr. Becker Rhein-Sieg-Klinik Nümbrecht; Institute of Medical Statistics, Informatics and Epidemiology and Institute for Health Economics and Clinical Epidemiology, University of Cologne; Faculty of Business Management and Social Sciences, Osnabrück University of Applied Sciences; Institute of Medical Sociology, Health Services Research, and Rehabilitation Science (IMVR), University of Cologne & University Hospital Cologne.
Thalidomide survivors experience mental disorders twice as often as the general population. Despite high need, psychosocial healthcare utilization remains low, indicating a significant unmet need for specialized services.
Area of Science:
- Psychiatry
- Medical Sociology
- Public Health
Background:
- Thalidomide's legacy includes persistent orthopedic and psychosocial issues for affected individuals.
- Over 50 years post-market withdrawal, mental health remains a significant concern for thalidomide survivors.
Purpose of the Study:
- To determine the prevalence of mental disorders in individuals affected by thalidomide.
- To assess the utilization of mental health services among this population.
Main Methods:
- A cohort of 193 thalidomide-affected individuals underwent psychodiagnostic testing.
- Utilized Structured Clinical Interview for DSM-IV (SCID-I & SCID-II) and self-reporting questionnaires for comprehensive assessment.
Main Results:
- The four-week prevalence of mental disorders was 47.2%, with 45.1% experiencing multiple diagnoses.
- Unipolar depressive, somatoform, phobic, and alcohol-related disorders were most common.
- 80.2% with current mental disorders required immediate care, yet only 29.7% accessed psychosocial treatment in the past year.
Conclusions:
- Thalidomide-affected individuals exhibit mental disorders at nearly double the rate of the general population.
- A significant underuse of psychosocial healthcare services is evident in this group.
- Specialized treatment services are needed to improve access and address healthcare barriers.
Related Concept Videos
Teratogenicity
Disorders of the Nervous Tissue
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Diagnostic and Statistical Manual of Mental Disorders (DSM)
Post-traumatic Stress Disorder
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events, are a...
Dissociative Identity Disorder
Bipolar Disorder

